Graft Use in Transvaginal Pelvic Organ Prolapse RepairVivian W. Sung, Stephen B. Young, Rebecca G. Rogers et al.|Obstetrics and Gynecology|2008Cited by 163
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 studyKevin H.M. Kuo, Elliott Vichinsky, D. Mark Layton et al.|The Lancet|2022Cited by 87
ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-ThalassemiaMaria Domenica Cappellini, Antonis Kattamis, Sujit Sheth et al.|Blood|2024Cited by 14
Long-Term Efficacy and Safety of the Oral Pyruvate Kinase Activator Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-ThalassemiaKevin H.M. Kuo, Elliott Vichinsky, D. Mark Layton et al.|Blood|2021Cited by 7
Mitapivat Improves Markers of Erythropoietic Activity in Long-Term Study of Adults with Alpha- or Beta-Non-Transfusion-Dependent ThalassemiaKevin H.M. Kuo, Elliott Vichinsky, D. Mark Layton et al.|Blood|2022Cited by 6